Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1702242
PUBLISHER: IMARC | PRODUCT CODE: 1702242
Alpha Emitter Market Size, Share, Trends and Forecast by Type of Radionuclide, Medical Application, End User, and Region, 2025-2033
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global alpha emitter market size was valued at USD 1,834.48 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 12,040.20 Million by 2033, exhibiting a CAGR of 23.25% from 2025-2033. North America currently dominates the market, holding a market share of over 43.7% in 2024. Factors such as the increasing focus on targeted cancer treatments, along with the rising number of new nuclear-medicine-based product approvals, are bolstering the alpha emitter market share.
Alpha emitters are substances emitted by radioactive sources that decay after releasing alpha particles. They achieve appropriate biodistribution and associated dose distribution to achieve effective therapy without causing unacceptable acute or long-term side effects. With their exceptionally high cell-killing rates, alpha particles are more destructive to tumor cells than beta particles when used in medical procedures. Consequently, they cause less damage to adjacent normal tissues. Radium, lead and bismuth are some of the radionuclides used in the treatment process. The short range and high linear energy transfer (LET) of alpha particles have made them remarkably appealing to medical research, particularly as a viable treatment method for cancer. There are numerous types of cancer that can be treated with alpha emitters, including ovarian cancer, pancreatic cancer, lymphoma, and melanoma.
Alpha Emitter Market Trends:
The market is majorly driven by extensive and high-end research and development (R&D) activities being conducted in cancer treatment. This can be attributed to the growing awareness regarding the cell-killing abilities of targeted alpha emitters. In line with this, the rising prevalence of various types of cancer among the masses is providing an impetus to the market. Also, the increasing geriatric population that is susceptible to develop numerous cardiac and cancer ailments is creating a positive outlook for the market. Moreover, the rising adoption of targeted anticancer or alpha therapy (TAT) in healthcare facilities is impacting the market positively. The market is further propelled by continual technological advancements and the growing number of new nuclear-medicine-based product approvals. Some of the other factors contributing to the market include rapid urbanization, continual improvements in healthcare infrastructure, rising medical expenditure and inflating disposable income levels of the individuals.
Key Market Segmentation:
Breakup by Type of Radionuclide:
- Astatine
- Radium
- Actinium
- Lead
- Bismuth
- Others
Breakup by Medical Application:
- Prostate Cancer
- Bone Metastasis
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
Breakup by End User:
- Hospitals
- Medical Research Institutions
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.
Key Questions Answered in This Report
- 1.How big is the alpha emitter market?
- 2.What is the future outlook of alpha emitter market?
- 3.What are the key factors driving the alpha emitter market?
- 4.Which region accounts for the largest alpha emitter market share?
- 5.Which are the leading companies in the global alpha emitter market?
Product Code: SR112025A6398
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Alpha Emitter Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type of Radionuclide
- 6.1 Astatine
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Radium
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Actinium
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Lead
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Bismuth
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Medical Application
- 7.1 Prostate Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Bone Metastasis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Ovarian Cancer
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pancreatic Cancer
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Endocrine Tumors
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Medical Research Institutions
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Actinium Pharmaceuticals Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.2 Alpha Tau Medical Ltd.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Bayer AG
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Fusion Pharmaceuticals
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.5 IBA RadioPharma Solutions
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 RadioMedix Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.1 Actinium Pharmaceuticals Inc.
Product Code: SR112025A6398
List of Figures
- Figure 1: Global: Alpha Emitter Market: Major Drivers and Challenges
- Figure 2: Global: Alpha Emitter Market: Sales Value (in Million USD), 2019-2024
- Figure 3: Global: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 4: Global: Alpha Emitter Market: Breakup by Type of Radionuclide (in %), 2024
- Figure 5: Global: Alpha Emitter Market: Breakup by Medical Application (in %), 2024
- Figure 6: Global: Alpha Emitter Market: Breakup by End User (in %), 2024
- Figure 7: Global: Alpha Emitter Market: Breakup by Region (in %), 2024
- Figure 8: Global: Alpha Emitter (Astatine) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Alpha Emitter (Astatine) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Alpha Emitter (Radium) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Alpha Emitter (Radium) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Alpha Emitter (Actinium) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Alpha Emitter (Actinium) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Alpha Emitter (Lead) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Alpha Emitter (Lead) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Alpha Emitter (Bismuth) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Alpha Emitter (Bismuth) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Alpha Emitter (Other Type of Radionuclides) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Alpha Emitter (Other Type of Radionuclides) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Alpha Emitter (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Alpha Emitter (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Alpha Emitter (Bone Metastasis) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Alpha Emitter (Bone Metastasis) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Alpha Emitter (Ovarian Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Alpha Emitter (Ovarian Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Alpha Emitter (Pancreatic Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Alpha Emitter (Pancreatic Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Alpha Emitter (Endocrine Tumors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Alpha Emitter (Endocrine Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Alpha Emitter (Other Medical Applications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Alpha Emitter (Other Medical Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: Global: Alpha Emitter (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: Global: Alpha Emitter (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Global: Alpha Emitter (Medical Research Institutions) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Global: Alpha Emitter (Medical Research Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Global: Alpha Emitter (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Global: Alpha Emitter (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: North America: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: North America: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: United States: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: United States: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Canada: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Canada: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Asia-Pacific: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Asia-Pacific: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: China: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: China: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Japan: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Japan: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: India: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: India: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: South Korea: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: South Korea: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Australia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Australia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Indonesia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Indonesia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Europe: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Europe: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Germany: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Germany: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: France: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: France: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: United Kingdom: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: United Kingdom: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Italy: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Italy: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Spain: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Spain: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Russia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Russia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Latin America: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Latin America: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Brazil: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Brazil: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 80: Mexico: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 81: Mexico: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 82: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 83: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 84: Middle East and Africa: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
- Figure 85: Middle East and Africa: Alpha Emitter Market: Breakup by Country (in %), 2024
- Figure 86: Middle East and Africa: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 87: Global: Alpha Emitter Industry: SWOT Analysis
- Figure 88: Global: Alpha Emitter Industry: Value Chain Analysis
- Figure 89: Global: Alpha Emitter Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Alpha Emitter Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Alpha Emitter Market Forecast: Breakup by Type of Radionuclide (in Million USD), 2025-2033
- Table 3: Global: Alpha Emitter Market Forecast: Breakup by Medical Application (in Million USD), 2025-2033
- Table 4: Global: Alpha Emitter Market Forecast: Breakup by End User (in Million USD), 2025-2033
- Table 5: Global: Alpha Emitter Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Alpha Emitter Market: Competitive Structure
- Table 7: Global: Alpha Emitter Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.